Dynamic response to therapy is strongly associated with cancer outcomes. We aim to develop the response-adapted individualized risk index (RAIRI) as an individual prognostic approach and predictive biomarker for adjuvant chemotherapy (AC) benefit in…
Continue Reading
Elisabeth Thijssen, PhD, Chief Scientific Officer of Neurogen Biomarking.
What You Should Know:
– Advancements in accelerating early Alzheimer’s disease (AD) screening and access to care, proven from three diverse community pilot initiatives, were presented today…
Continue Reading
Rameez Chatni, Global Director AI Solutions—Pharmaceutical and Life Sciences at Cloudera
As precision medicine continues to reshape the future of healthcare, clinical trials are evolving from one-size-fits-all studies into highly targeted investigations driven by genomics…
Continue Reading
What You Should Know:
– Ultrahuman, the pioneering health optimization company behind the Ultrahuman Ring and M1 (an advanced Continuous Glucose Monitoring platform), today announced the nationwide expansion of Blood Vision, now available across 48…
Continue Reading
Rare gynecological tumors (RGTs) present major clinical challenges due to their low incidence and heterogeneity. The lack of clear guidelines leads to suboptimal management and poor prognosis. Molecular tumor boards accelerate access to effective…
Continue Reading
LLM for functional medicine developed in MalaysiaEmagene.Life, an alternative medicine provider focused on longevity, has unveiled a large language model-based (LLM) platform for functional medicine.
Based on a media release, the LLM-driven platform provides insights into…
Reproductive aging impacts women’s health through fertility decline, disease susceptibility, and systemic aging. This study explores the retinal age gap—the difference between predicted retinal age and chronological age—as a novel biomarker for reproductive aging….
Continue Reading
Ellipsis Health, a company using AI voice agent technology, announced the close of a $45 million Series A funding roundSalesforce, Khosla Ventures and CVS Health Ventures led the round. Mitsui Global Investment, Collier, E12…
Continue Reading
Retinal age has emerged as a promising biomarker of aging, offering a non-invasive and accessible assessment tool. We developed a deep learning model to estimate retinal age with enhanced accuracy, leveraging retinal images from…
Continue Reading
What You Should Know:
– Neurogen Biomarking announced a strategic partnership with NeuroX, a venture of American TelePhysicians, to integrate virtual neurology services into Neurogen’s innovative brain health care ecosystem. The collaboration aims to…
Continue Reading
